Lung cancer could be identified earlier with a new blood test A new blood test that evaluates four protein biomarkers significantly improves the likelihood of identifying lung cancer risk, according to IARC, quoted Thursday by EFE

This method helps to identify those who should perform a TAC, a radiological radiological examination traditionally used to diagnose this disease.

One of the principal investigators of the study, Mattias Johansson, said that the EFE was "the first time that a blood test is used as part of the early detection lung cancer in predisposed individuals. "

This new model takes into account tobacco consumption and analyzes blood levels of CA125, Pro-SFTPB, CYFRA 21-1 and CEA, some of which, such as CYFRA 21-1 , are already examined individually to diagnose other cancers such as ovarian cancer.

The study analyzed the blood of some lung cancer patients when the disease was still in the state

The new system, according to Johansson, identified among smokers and ex-smokers 63% of future patients, while the percentage

IARC Director Christopher Wild said in a press release that "tobacco avoidance is the best way to reduce the risk of developing cancer. smokers and older smokers, early detection has a key role to play in the fight against this disease. "

Lung cancer accounts for 20% of all cancer deaths in the world, and most of them 80-90% are caused by smoking, according to IARC – entity that is part of the World Health Organization (WHO) . s) {if (f.fbq) return; n = f.fbq = function () {n.callMethod?
n.callMethod.apply (n arguments): (! f._fbq) n.queue.push (arguments)} if f._fbq = n;
n.push = n; n.loaded = 0; n.version = 2.0 & # 39 ;; n.queue = []; t = b.createElement (s) t.async = 0 !;
t.src = V s = b.getElementsByTagName (s) [0]; s.parentNode.insertBefore (t, s)} (window,
document "script", https: //connect.facebook.net/en_US/fbevents.js');